Literature DB >> 25839764

Association between serum uric acid and nonalcoholic fatty liver disease in the US population.

Ming-Hsiung Shih1, Mariana Lazo2, Su-Hsun Liu2, Susanne Bonekamp3, Ruben Hernaez4, Jeanne M Clark5.   

Abstract

BACKGROUND/
PURPOSE: Studies conducted in Eastern Asia suggest that serum uric acid (SUA) level is highly related to nonalcoholic fatty liver disease (NAFLD). However, limited information is available in the USA. Our objective was to determine the association between NAFLD and SUA levels in the USA and to determine if this is independent of age, sex, and components of metabolic syndrome (MetS).
METHODS: We analyzed 5370 men and women aged 20-74 years from the Third National Health and Nutrition Examination Survey (NHANES III) (1988-1994) in the USA. We calculated the prevalence and odds ratio (OR) of NAFLD and elevated liver enzymes by SUA and sex-specific quintiles of SUA, adjusting for multiple factors.
RESULTS: The prevalence of NAFLD was higher in participants with higher SUA levels (10.9%, 9.6%, 15.9%, 21.8% and 33.1%, respectively, from the second to the fifth sex-specific quintile of uric acid). After adjustment, individuals with hyperuricemia were more likely to have NAFLD (OR: 1.4, 95% CI: 1.1-1.9). Similarly, the adjusted odds of NAFLD were increasingly higher from the second to the fifth quintile of SUA (ORs: 0.8, 1.2, 1.5 and 1.7, respectively; p < 0.01) as compared to the lowest quintile. Finally, individuals with hyperuricemia were more likely to have elevated liver enzymes (aspartate aminotransferase or alanine aminotransferase) (adjusted OR: 1.8, 95% CI: 1.1-2.7).
CONCLUSION: NAFLD and SUA levels were strongly and independently associated in this nationally representative sample of men and women after adjustment for multiple factors.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Keywords:  hyperuricemia; nonalcoholic fatty liver disease; serum uric acid

Mesh:

Substances:

Year:  2013        PMID: 25839764      PMCID: PMC6312686          DOI: 10.1016/j.jfma.2012.11.014

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  20 in total

Review 1.  Gout and Metabolic Syndrome: a Tangled Web.

Authors:  Gabrielle E Thottam; Svetlana Krasnokutsky; Michael H Pillinger
Journal:  Curr Rheumatol Rep       Date:  2017-08-26       Impact factor: 4.592

Review 2.  Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back.

Authors:  Chengfu Xu
Journal:  Hepatol Int       Date:  2015-12-15       Impact factor: 6.047

3.  Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective Studies.

Authors:  Zhengtao Liu; Shuping Que; Lin Zhou; Shusen Zheng
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

4.  Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males.

Authors:  Zhiwei Zhou; Kai Song; Jing Qiu; Yiying Wang; Chunxing Liu; Hui Zhou; Yunfang Xu; Zhirong Guo; Biao Zhang; Chen Dong
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

5.  Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults.

Authors:  Chang-Qin Liu; Chun-Mei He; Ning Chen; Dongmei Wang; Xiulin Shi; Yongwen Liu; Xin Zeng; Bing Yan; Suhuan Liu; Shuyu Yang; Xiaoying Li; Xuejun Li; Zhibin Li
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

Review 6.  Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review.

Authors:  Usama A A Sharaf El Din; Mona M Salem; Dina O Abdulazim
Journal:  J Adv Res       Date:  2016-12-03       Impact factor: 10.479

7.  Phytosterol esters attenuate hepatic steatosis in rats with non-alcoholic fatty liver disease rats fed a high-fat diet.

Authors:  Lihua Song; Dan Qu; Qing Zhang; Jing Jiang; Haiyue Zhou; Rui Jiang; Yating Li; Yao Zhang; Hongli Yan
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

8.  Higher Blood Uric Acid in Female Humans and Mice as a Protective Factor against Pathophysiological Decline of Lung Function.

Authors:  Haruka Fujikawa; Yuki Sakamoto; Natsuki Masuda; Kentaro Oniki; Shunsuke Kamei; Hirofumi Nohara; Ryunosuke Nakashima; Kasumi Maruta; Taisei Kawakami; Yuka Eto; Noriki Takahashi; Toru Takeo; Naomi Nakagata; Hiroshi Watanabe; Koji Otake; Yasuhiro Ogata; Naoko H Tomioka; Makoto Hosoyamada; Tappei Takada; Keiko Ueno-Shuto; Mary Ann Suico; Hirofumi Kai; Junji Saruwatari; Tsuyoshi Shuto
Journal:  Antioxidants (Basel)       Date:  2020-05-06

Review 9.  Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research.

Authors:  Amedeo Lonardo; Ayako Suzuki
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

Review 10.  Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.

Authors:  Changyi Chen; Jian-Ming Lü; Qizhi Yao
Journal:  Med Sci Monit       Date:  2016-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.